UK pharmaceutical giant GSK has confirmed that it has signed an agreement to acquire the privately-held biotechnology company IDRx.
The Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMG-MAN) expressed serious concerns over the scarcity of foreign exchange in Nigeria, stating that it is impossible for pharmaceutical companies to cope.
The Nigerian Exchange Limited (NGX) has delisted the Shares of GlaxoSmithKline Consumer Nigeria (GSK) Plc from its Daily Official List of NGX.
The Nigerian Exchange Limited (NGX) has suspended trading on the shares of Glaxo SmithKline Consumer Nigeria (GSK) Plc for eventual delisting from the Exchange.
The Board of GlaxoSmithKline Consumer Nigeria Plc (GSK) has announced that the Company has received the Securities and Exchange Commission’s formal approval of its scheme of arrangement which will result in delisting from the Nigerian Exchange Limited (NGX).
LSHTM and GSK are offering scholarships to support the training and development of the next generation of leaders in global health in Africa.
Shareholders of GSK Consumer Nigeria Plc have approved the payment of N17.42 for every share held by its shareholders.
Medications worth N81.81 billion were imported into Nigeria from July to September 2023.
Cameroon achieved a milestone in the battle against malaria as it welcomed the initial shipment of Mosquirix malaria vaccines from GSK.
Following the recent announcement of GlaxoSmithKline's (GSK) departure from the Nigerian pharmaceutical market, there has been a notable surge in the prices of GSK medications, with increases reported to be as high as 1000%.
GSK has signed a deal with Zhifei, China’s largest vaccine company by revenue, as the British drugmaker aims to double global sales of its shingles vaccine by 2026.
NAFDAC has clarified that the exit of GSK pharmaceutical company is not the cause of the increase in drug prices in the country but rather the fall in the valuation of naira.
